Axsome Therapeutics Inc (AXSM)
90.02
-0.68
(-0.76%)
USD |
NASDAQ |
Nov 08, 16:00
90.02
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Revenue (Annual): 270.60M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 270.60M |
Date | Value |
---|---|
December 31, 2022 | 50.04M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
50.04M
Minimum
2022
270.60M
Maximum
2023
160.32M
Average
160.32M
Median
Revenue (Annual) Benchmarks
Krystal Biotech Inc | 50.70M |
Pfizer Inc | 58.50B |
Sarepta Therapeutics Inc | 1.243B |
Moderna Inc | 6.754B |
NovaBay Pharmaceuticals Inc | 14.73M |